A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Condition: Lymphoma, Non-Hodgkin Intervention: Drug: DZD8586 Sponsor: Dizal Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials